Clorox (CLX) director adds to deferred stock unit holdings through awards

Rhea-AI Filing Summary

The Clorox Company director reports routine deferred stock awards. A board member of Clorox (ticker CLX) reported several grants of deferred stock units that each convert 1-for-1 into Clorox common stock. On 11/06/2025, the director acquired 219.3396 deferred stock units, bringing the beneficial holding to 19,018.8638 units. On 12/31/2025, additional awards of 1,219.1572 and 145.2617 deferred stock units increased the total to 20,383.2827 units held directly.

The filing explains that some units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan, some represent the annual deferred stock unit award under the 2005 Stock Incentive Plan, and some reflect stock units received instead of a portion of quarterly director fees. All deferred stock units will be settled entirely in Clorox stock when the director retires or otherwise leaves the board.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fleischer Spencer C

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	11/06/2025		A(2)	V	219.3396		(3)	(3)	Common Stock	219.3396	$0.0000	19,018.8638	D
Deferred Stock Units	(1)	12/31/2025		A(4)		1,219.1572		(3)	(3)	Common Stock	1,219.1572	$0.0000	20,238.021	D
Deferred Stock Units	(1)	12/31/2025		A(5)		145.2617		(3)	(3)	Common Stock	145.2617	$0.0000	20,383.2827	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

5. Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity at Clorox (CLX) is disclosed in this filing?

The filing shows a Clorox director acquiring several grants of deferred stock units that each convert 1-for-1 into Clorox common stock, increasing the director's deferred holdings.

How many Clorox deferred stock units does the director hold after these transactions?

After the reported transactions on 11/06/2025 and 12/31/2025, the director beneficially owns 20,383.2827 deferred stock units directly.

On what dates were the new Clorox (CLX) deferred stock unit awards made?

The reported deferred stock unit transactions occurred on 11/06/2025 and 12/31/2025, as shown in the derivative securities table.

What were the sizes of the Clorox deferred stock unit grants in this Form 4?

The director received grants of 219.3396, 1,219.1572, and 145.2617 deferred stock units, all with an exercise price of $0.0000 per unit.

How will the Clorox (CLX) deferred stock units reported here be settled?

The filing states that all reported deferred stock units will be settled 100% in Clorox stock when the director retires or otherwise terminates service as a director.

Why did the Clorox director receive these deferred stock units?

According to the explanations, units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan, through an annual award under the 2005 Stock Incentive Plan, and as deferred units in lieu of part of quarterly director fees.

Is this Clorox (CLX) insider transaction a purchase or part of compensation programs?

The reported activity reflects compensation-related deferred stock units and dividend reinvestments under established director plans, rather than open-market stock purchases.